Impact of Endotest on Patients' Quality of Life: a Cohort Study
This study is investigating a new saliva test called Endotest, which helps diagnose endometriosis. Endometriosis is a condition where tissue similar to the lining of the womb grows outside of it, causing pain and other symptoms. This study aims to understand how getting the Endotest result, whether positive or negative, impacts women's quality of life, their emotional well-being, how they cope, and their healthcare journey. Researchers will use questionnaires and information from medical records to gather this information. The goal is to collect reliable information that will be helpful for both doctors and patients, ultimately improving how endometriosis is managed.
At a glance
What is this study about?
This study is looking into a new test called Endotest, which helps diagnose a condition called endometriosis. Endometriosis is when tissue similar to the lining of the womb grows elsewhere in the body, often causing pain and other difficulties. The Endotest is a simple saliva test that helps doctors identify if someone has endometriosis. It was first introduced in Switzerland and is now becoming available in France.
The main aim of this study is to understand how the Endotest affects the lives of women who use it. Researchers want to find out if getting the test results, whether they indicate endometriosis or not, changes how women feel, their overall well-being, and how they manage their condition. They also want to see if it helps women get care more quickly and smoothly.
While we know the test can help diagnose endometriosis, this study will explore something different. It will check if the test genuinely improves things like a patient's quality of life and their journey through the healthcare system. By gathering information from many patients using questionnaires and their medical notes, the study hopes to provide clear evidence that will be useful for both doctors and patients in making decisions about endometriosis care.
Key takeaways
- The study explores how a new saliva test (Endotest) affects women with endometriosis.
- It aims to understand its impact on quality of life and healthcare journeys.
- Participation involves filling out questionnaires and allowing access to medical records.
- The study doesn't require new treatments or extra clinic visits.
- Results will help improve endometriosis care for future patients.
Who may be eligible?
To be part of this study, you need to be a woman between 18 and 43 years old and have been given a prescription for the Endotest. You also need to live in France and be part of the French healthcare system, or have health insurance if you're from abroad.
You cannot take part if you are currently pregnant, have a history of cancer, or have HIV. Also, if you have an infection when it's time to provide a saliva sample, you generally can't join. Finally, if you have significant trouble reading and understanding French, you wouldn't be able to participate.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- Are you a woman between 18 and 43 years old?
- Has your doctor prescribed you the Endotest?
- Are you currently pregnant, or do you have a history of cancer or HIV?
- Do you have a current infection that would prevent a saliva test?
- Can you easily read and understand English (or the local language if in France)?
What does participation involve?
If you join this study, you will have been prescribed the Endotest by your doctor. You will be asked to complete some questionnaires. These questionnaires will ask about your quality of life, your feelings, and how you are coping. Researchers will also look at information from your medical records to understand your healthcare journey. The study does not involve any extra doctor visits or taking new medications, beyond what your doctor has already prescribed. The total time you would be involved in the study would depend on when you complete the questionnaires, but it mainly focuses on collecting information through these surveys and existing medical data.
Potential risks and benefits
Locations (7)
- Clinique Tivoli DucosVerified postcodeBordeaux, France· Recruiting
- Hôpital privé Saint-GrégoireVerified postcodeSaint-Grégoire, France· Not yet recruiting
- Groupe Hospitalier Bretagne Sud - GHBS - LorientVerified postcodeLorient, France· Not yet recruiting
- Hôpital de Mercy - CHR Metz ThionvilleVerified postcodePeltre, France· Not yet recruiting
- CHU de Saint EtienneApproximateSaint-Priest-en-Jarez, France· Not yet recruiting
- Centre Hospitalier de PauVerified postcodePau, France· Not yet recruiting
- Hôpital Jacques Monod - GH du HavreVerified postcodeMontivilliers, France· Not yet recruiting
Common questions
What is endometriosis?
Endometriosis is a condition where tissue similar to the lining of the womb grows outside of it, often causing pain and other symptoms.
What is the Endotest?
The Endotest is a new saliva test designed to help diagnose endometriosis.
Will I have to take new medicine?
No, this study does not involve taking any new medications. You will only continue with treatments your own doctor has prescribed.
How long will I be in the study?
The study collects information through questionnaires and your medical records, so your active involvement will depend on when you complete the survey parts.
Can I leave the study if I change my mind?
Yes, you can leave the study at any point without needing to give a reason, and it will not affect your medical care.
How to find out more
Fabien Le Floc'h, Project Manager
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.